Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma.
Hamlin PA, Musteata V, Park SI, Burnett C, Dabovic K, Strack T, Williams ET, Anand BS, Higgins JP, Persky DO. Hamlin PA, et al. Among authors: dabovic k. Cancer Res Commun. 2022 May 5;2(5):307-315. doi: 10.1158/2767-9764.CRC-22-0056. eCollection 2022 May. Cancer Res Commun. 2022. PMID: 36875713 Free PMC article. Clinical Trial.
A first-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending oral dose study to assess the safety, tolerability, and pharmacokinetics of BZF961 with and without ritonavir in healthy adult volunteers.
Youngberg S, Brandt E, Barve A, Machineni S, Jones CT, Dabovic K, Jones CL, Colvin RA. Youngberg S, et al. Among authors: dabovic k. J Drug Assess. 2018 Oct 24;7(1):66-74. doi: 10.1080/21556660.2018.1535438. eCollection 2018. J Drug Assess. 2018. PMID: 30370176 Free PMC article.
The Safety and Antiviral Activity of BZF961 with or without Ritonavir in Patients Infected with Hepatitis C Virus: A Randomized, Multicenter Trial.
Lawitz E, Bidair M, Marbury T, Jones CT, Barve A, Magnusson B, Barkan DT, Bodendorf U, Bracken K, Canino E, Chen D, Dabovic K, Heimbach T, Ison M, Jones CL, Kovacs SJ, Lakshman JP, Li B, Raman P, Steiner-Swiat R, Thohan S, Wong KA, Zhong W, Colvin RA. Lawitz E, et al. Among authors: dabovic k. Clin Ther. 2018 Sep;40(9):1567-1581.e4. doi: 10.1016/j.clinthera.2018.07.019. Epub 2018 Sep 2. Clin Ther. 2018. PMID: 30185394 Clinical Trial.
Multicenter, randomized clinical trial to compare the safety and efficacy of LFF571 and vancomycin for Clostridium difficile infections.
Mullane K, Lee C, Bressler A, Buitrago M, Weiss K, Dabovic K, Praestgaard J, Leeds JA, Blais J, Pertel P. Mullane K, et al. Among authors: dabovic k. Antimicrob Agents Chemother. 2015 Mar;59(3):1435-40. doi: 10.1128/AAC.04251-14. Epub 2014 Dec 22. Antimicrob Agents Chemother. 2015. PMID: 25534727 Free PMC article. Clinical Trial.
The kinetic mechanism of phosphomevalonate kinase.
Pilloff D, Dabovic K, Romanowski MJ, Bonanno JB, Doherty M, Burley SK, Leyh TS. Pilloff D, et al. Among authors: dabovic k. J Biol Chem. 2003 Feb 14;278(7):4510-5. doi: 10.1074/jbc.M210551200. Epub 2002 Nov 6. J Biol Chem. 2003. PMID: 12424232 Free article.